PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today the completion of a Phase 2b study for AOBiome, a clinical-stage life ...
MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a Phase 3 rare disease ...
MORRISVILLE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced that it has been awarded the Research and Development - Site ...
A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has found that the drug mavoglurant can reduce use in people with cocaine use ...
Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...
NEW YORK – August 27, 2024 – The Cardiovascular Research Foundation ® (CRF ®) is pleased to announce the late-breaking clinical trials and science to be featured at TCT ® 2024. As the annual ...
Institutions that conduct clinical trials — such as pharmaceutical companies and universities — still do a poor job following a law that requires them to post clinical trial results on a government ...
This year is the centennial of one of the most celebrated trials in American history. In Dayton, Tennessee, a local schoolteacher, John Scopes, volunteered to be the defendant. He was prosecuted for ...
We preselected all newsletters you had before unsubscribing.
Reporters from across the United States flocked to eastern Tennessee in July 1925. In the small town of Dayton, biology teacher John Scopes went on trial for the crime of teaching human evolution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results